Ghrelin (OXE-103)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ghrelin (OXE-103), covering 2024-05-21 to 2024-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Ghrelin (OXE--103) for Acute Concussion Management [Phase 2]